|
|
|
| The Advanced Method of Kidney and Lung De-Cellularized Scaffold through in vitro Perfusion |
| Chen Pianpian, Lin Qian, Zhu Qunyan, Zhao Yingzheng* |
| (School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzho 325035u, Zhejiang, China) |
|
[1] 王小军. 去细胞化的肝脏支架在细胞移植中的应用研究[D]. 重庆: 第三军医大学, 2013.
[2] 王康华. 选择适宜的灌注去细胞方法应用于全肝脏去细胞支架的制备[D]. 广州: 南方医科大学, 2015.
[3] 黑飞龙. 灌注法大鼠全肺脏脱细胞基质支架的建立[J]. 北京生物医学工程, 2013, 32(1) :17-21.
[4] Vavken P, Joshi S, Murray MM, et al. TRITON-X is most effective among three decellularization agents for ACL tissue engineering[J]. Journal of Orthopaedic Research, 2009, 27(12):1612-1618.
[5] 孙赳. 肝素修饰改善去细胞化猪肝脏支架材料的生物相容性[D]. 泸州: 泸州医学院, 2014.
[6] Mallick KK, Cox SC, et al. Biomaterial scaffolds for tissue engineering[J]. Frontiers in Bioscience (Elite edition), 2013, 1(5):341-360.
[7] Piccoli M, Urbani L, Alvarez-Fallas ME, et al. Improvement of diaphragmatic performance through orthotopic application of decellularized extracellular matrix patch[J]. Biomaterials, 2016, 1(74):245-255.
[8] Chen RN, Ho HO, Tsai YT, et al. Process development of an acellular dermal matrix (ADM) for biomedical applications[J]. Biomaterials, 2004, 25(13):2679-2686.
[9] Sjoqvist S, Lim ML, et al. Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats[J]. Nature Communications, 2014, 5(15):3562.
[10] Koch H, Graneist C, Emmrich F, et al. Xenogenic esophagus scaffolds fixed with several agents: comparative in vivo study of rejection and inflammation[J]. Journal of Biomedicine & Biotechnology,2012, 2012: 948320.
[11] Elliott MJ, De Coppi P, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study[J]. Lancet, 2012, 380(9846):994-1000.
[12] Macchiarini P, Jungebluth P, Go T, Asnaghi MA, et al. Clinical transplantation of a tissue-engineered airway[J]. Lancet, 2008, 372(9655):2023-2030.
[13] Atluri P, Trubelja A, Fairman AS, et al. Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct[J]. Circulation, 2013, 128(11 Suppl 1):S95-S104.
[14] Badylak SF, Kochupura PV, Cohen IS, et al. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium[J]. Cell transplantation, 2006, 15 Suppl 1:S29-S40.
[15] Kochupura PV, Azeloglu EU, Kelly DJ, et al. Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function[J]. Circulation, 2005, 112(9 Suppl):I144-I149.
[16] Jang JU, Lee SH, Choi CU,et al. Effects of heme oxygenase-1 inducer and inhibitor on experimental autoimmune uveoretinitis[J]. Korean Journal of Ophthalmology, 2007, 21(4):238-243.
[17] 陈捷. 灌注法制备大鼠全肾脏脱细胞基质的细胞相容性研究[D]. 广州: 南方医科大学, 2010.
[18] Crapo PM, Gilbert TW, Badylak SF, et al. An overview of tissue and whole organ decellularization processes[J]. Biomaterials, 2011, 32(12):3233-3243.
[19] Song JJ, Ott HC, et al. Organ engineering based on decellularized matrix scaffolds[J]. Trends in Molecular Medicine, 2011, 17(8):424-432.
[20] Agrawal V, Kelly J, Tottey S, et al. An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation[J]. Tissue Engineering Part A, 2011, 17(23-24):3033-3044. |
|
|
|
